GSK Malaysia recalls one batch of Zyrtec-D tablets


KUALA LUMPUR: GlaxoSmithKline Malaysia (GSK) has recalled its Zyrtec-D (120mg/5mg Tablets x400) Allergy Relief and Nasal Decongestant Tablets batch number 321907 with the expiry date January 2025 printed on the blister pack.

GSK, in a statement Thursday (March 30), said that the decision to recall the product is a precautionary measure after some units were found to have blisters that were incorrectly sealed.

"All tablet packs and/or blisters from this batch are being recalled at all levels in the Malaysian market, including those already dispensed to patients.

"GSK is requesting all patients who have been dispensed Zyrtec-D tablets from any in-country retail, pharmacy or healthcare outlet to return the product with immediate effect to the original point of purchase, within the next 15 days,” read the statement.

GSK also urged all healthcare professionals to immediately cease prescribing, dispensing, selling, or distributing product from this batch, while patients should seek advice from their healthcare provider on alternative treatments.

GSK added that at present, there is no evidence that any other batches are affected, and no other complaints have been received about this product from any market since 2018.

The company added that the recall does not affect Zyrtec Drop 10mg/ml, Zyrtec Solution 1mg/ml and Zyrtec Tablet 10mg, and patients may continue these medications.

Consumers or healthcare providers with questions regarding this recall may contact GSK at +603-7495 2600 on Monday to Friday from 9am to 5pm, or by e-mail at my.corporatecommunications@gsk.com.

"Patients who have been prescribed and dispensed products from this batch and have concerns should contact their healthcare provider first.

"Pharmacies, clinics and hospitals that have recalled products to be returned, please contact Zuellig Pharma Sdn Bhd at 1-800 88 1388 or email csc@zuelligpharma.com.

"Any matter related to Human Safety Information/ Adverse Event, please contact GSK Pharmacovigilance via email at drugsafetyinfo.my@gsk.com,” the statement added. - Bernama

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

M'sians in HK gather to celebrate Dr Thein's Shaw Prize success
Post-mortem continues for woman found in freezer, say cops
VIP escort and covert manoeuvre training in Taiping from Nov 15 to Dec 2
Dr Wee ready to face rights and privileges committee, slams Kampar MP for twisting facts
Police revisit Taman OUG after discovery of woman’s remains in freezer
Duo nabbed hours after robbing Sg Petani store, cops uncover cache of explosives, drugs
Rat droppings, filthy floor found in two Penang eateries
Flash floods at Subang Jaya station disrupting KTM Komuter services
Northeast Monsoon: Ministry to ensure essential supplies are accessible, fairly priced, says Armizan
Corruption case death threats: Police, MCMC tracking those involved

Others Also Read